BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 25, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

LG631-CD34 regulatory update

Lentigen said FDA granted Orphan Drug designation for LG631-CD34 for bone marrow protection in the...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >